Lipella Pharmaceuticals Other Current Liabilities

Lipella Pharmaceuticals (LIPO) currently reports a other current liabilities of $140M as of September 2025. That compares with $170M in the prior-year period — down 20.9% year over year. Use the charts on this page to explore Lipella Pharmaceuticals's other current liabilities history and peer comparisons.

Lipella Pharmaceuticals's other current liabilities decreased from $170M to $140M — a 20.9% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lipella Pharmaceuticals reported $140M in other current liabilities as of September 2025. That compares with $170M in the prior-year period — down 20.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $140M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lipella Pharmaceuticals, and consider following LIPO for alerts when major investors trade the stock.